Schedule 13D ownership disclosure

TriSalus Life Sciences Inc

Common Stock, $0.0001 par value · CUSIP: 89680M101

Event date: 2024-12-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Mats WahlstromReported CIK 0001459154

    Shares: 2,797,437.00 · Class: 9.0%

  • Kerry R. HicksReported CIK 0001110473

    Shares: 2,320,240.00 · Class: 7.5%

  • HW Investment Partners, LLCReported CIK 0001987394

    Shares: 1,370,028.00 · Class: 4.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-24-029847
Form type
SCHEDULE 13D/A
Filer
TriSalus Life Sciences, Inc.
CIK
CIK 1826667
Filed
Dec 19, 2024
Reporting period
Dec 17, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub